Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections mainly attack the lungs, in many cases they can also damage other organs, such as the colon: Around 60% of patients, in fact, experience digestive tract impacts. Researchers at MedUni Vienna, Austria, have analyzed the manifestations of COVID-19 in the lungs and colon and pinpointed the differences at a molecular level. Their findings, published recently in the International Journal of Molecular Sciences, may form the basis for the identification of novel biomarkers and the development of new treatment strategies.
展开▼
